Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Halperin

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Retina (Philadelphia, Pa.)|May 27, 2014
Retina specialists treating age-related macular degeneration recommend different approaches for patients than they would choose for themselvesKaren W Jeng, John Wilgucki, Scott Halperin, et al.
Vaccine|June 1, 2007
Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentationMichael Buettcher, Ulrich Heininger, Miles Braun, et al.
Journal of Clinical Immunology|May 15, 2014
High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccineKaren K Yam, Erica Gipson, Marina Klein, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerationsTina Tan, Scott Halperin, James D Cherry, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 27, 2011
The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccineEthan Rubinstein, Gerald Predy, Laura Sauvé, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
HIV Clinical Trials|February 7, 2012
High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adultsCurtis Cooper, Marina Klein, Sharon Walmsley, et al.
Human Vaccines & Immunotherapeutics|September 22, 2017
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platformLisa D MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, et al.
Vaccine|June 24, 2022
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approachesKirsten Maertens, Elke Leuridan, Flor M Munoz, et al.
Human Vaccines & Immunotherapeutics|March 2, 2021
Is 'conflict of interest' a Misnomer? Managing interests in immunization research and evaluationElisabeth McClymont, Jason Brophy, Vinita Dubey, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Retina (Philadelphia, Pa.)|May 27, 2014
Retina specialists treating age-related macular degeneration recommend different approaches for patients than they would choose for themselvesKaren W Jeng, John Wilgucki, Scott Halperin, et al.
Vaccine|June 1, 2007
Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentationMichael Buettcher, Ulrich Heininger, Miles Braun, et al.
Journal of Clinical Immunology|May 15, 2014
High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccineKaren K Yam, Erica Gipson, Marina Klein, et al.
The Pediatric Infectious Disease Journal|May 7, 2005
Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerationsTina Tan, Scott Halperin, James D Cherry, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 27, 2011
The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccineEthan Rubinstein, Gerald Predy, Laura Sauvé, et al.
Plos One|April 23, 2011
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adultsCurtis Cooper, Anona Thorne, Marina Klein, et al.
HIV Clinical Trials|February 7, 2012
High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adultsCurtis Cooper, Marina Klein, Sharon Walmsley, et al.
Human Vaccines & Immunotherapeutics|September 22, 2017
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platformLisa D MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, et al.
Vaccine|June 24, 2022
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approachesKirsten Maertens, Elke Leuridan, Flor M Munoz, et al.
Human Vaccines & Immunotherapeutics|March 2, 2021
Is 'conflict of interest' a Misnomer? Managing interests in immunization research and evaluationElisabeth McClymont, Jason Brophy, Vinita Dubey, et al.
Pageof 6